A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era. [electronic resource]
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Jun 2012
- 484-9 p. digital
Publication Type: Journal Article; Multicenter Study
1532-2157
10.1016/j.ejso.2012.01.011 doi
Adult Aged Antineoplastic Agents--therapeutic use Benzamides Chemotherapy, Adjuvant Female Follow-Up Studies Gastrectomy Gastrointestinal Stromal Tumors--drug therapy Humans Imatinib Mesylate Kaplan-Meier Estimate Male Middle Aged Neoplasm Recurrence, Local--prevention & control Neoplasm Staging Piperazines--therapeutic use Prospective Studies Pyrimidines--therapeutic use Risk Assessment Risk Factors Stomach Neoplasms--drug therapy Watchful Waiting